Penicillin in Borrelia burgdorferi-negative Primary Cutaneous Marginal Zone Lymphoma: A Case Series and Literature Review
DOI:
https://doi.org/10.2340/actadv.v102.198Abstract
Abstract is missing (Short communication)
Downloads
References
Hristov AC, Tejasvi T, Wilcox RA. Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 2020; 95: 1209-1213.
https://doi.org/10.1002/ajh.25970 DOI: https://doi.org/10.1002/ajh.25970
Ponzoni M, Ferreri AJM, Mappa S, Pasini E, Govi S, Facchetti F, et al. Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas. Oncologist 2011; 16: 1582-1588.
https://doi.org/10.1634/theoncologist.2011-0108 DOI: https://doi.org/10.1634/theoncologist.2011-0108
Monari P, Farisoglio C, Calzavara Pinton PG. Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report. Dermatology 2007; 215: 229-232.
https://doi.org/10.1159/000106580 DOI: https://doi.org/10.1159/000106580
Yildirim FE, Karaduman A, Hürmüz P, Ozyar E, Barişta I, Sağlam A. Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis. J Cutan Pathol 2010; 37: 600-604.
https://doi.org/10.1111/j.1600-0560.2009.01393.x DOI: https://doi.org/10.1111/j.1600-0560.2009.01393.x
Ghatalia P, Porter J, Wroblewski D, Carlson JA. Primary cutaneous marginal zone lymphoma associated with juxta-articular fibrotic nodules in a teenager. J Cutan Pathol 2013; 40: 477-484.
https://doi.org/10.1111/cup.12102 DOI: https://doi.org/10.1111/cup.12102
Bonin S, Stinco G, Patriarca MM, Trevisini S, di Meo N, Trevisan G. Could co-infection with anaplasma play a role in Borrelia-associated primary cutaneous marginal zone B-cell lymphomas? Indian J Dermatol Venereol Leprol 2016; 82: 81-84.
https://doi.org/10.4103/0378-6323.171011 DOI: https://doi.org/10.4103/0378-6323.171011
Jothishankar B, Di Raimondo C, Mueller L, Zain J, Parekh V, Abdulla F. Primary cutaneous marginal zone lymphoma treated with doxycycline in a pediatric patient. Pediatr Dermatol 2020; 37: 759-761.
https://doi.org/10.1111/pde.14165 DOI: https://doi.org/10.1111/pde.14165
Golling P, Cozzio A, Dummer R, French L, Kempf W. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leuk Lymphoma 2008; 49: 1094-1103.
https://doi.org/10.1080/10428190802064925 DOI: https://doi.org/10.1080/10428190802064925
Pirahmadi N, Zarghi A, Salimi A, Arefi H, Pourahmad J. β-lactam Structured, 4-(4-(Methylsulfonyl)phenyl)-1-pentyl-3-phenoxyazetidin-2-one: Selectively Targets Cancerous B Lymphocyte Mitochondria. Anticancer Agents Med Chem 2017; 17: 1292-1301.
https://doi.org/10.2174/1871520617666170213144113 DOI: https://doi.org/10.2174/1871520617666170213144113
Kuhlmann I. The prophylactic use of antibiotics in cell culture. Cytotechnology 1995; 19: 95-105.
https://doi.org/10.1007/BF00749764 DOI: https://doi.org/10.1007/BF00749764
Neftel KA, Müller MR, Widmer U, Hügin AW. Beta-lactam antibiotics inhibit human in vitro granulopoiesis and proliferation of some other cell types. Cell Biol Toxicol 1986; 2: 513-521.
https://doi.org/10.1007/BF00117853 DOI: https://doi.org/10.1007/BF00117853
Lim M, Bradshaw S, Kirchhof MG. Primary cutaneous low-grade B-cell lymphoma treated with hydroxychloroquine. JAAD Case Rep 2020; 6: 1048-1050.
https://doi.org/10.1016/j.jdcr.2020.08.003 DOI: https://doi.org/10.1016/j.jdcr.2020.08.003
Additional Files
Published
How to Cite
License
Copyright (c) 2022 Yang Wang, Yao Qin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
